Skip to content

Safety and efficacy of virtual reality mindfulness in patients with psychosis

Efficacy of virtual reality mindfulness in patients with psychosis and verification of changes in brain connectivity with fMRI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007718
Enrollment
50
Registered
2022-09-20
Start date
2020-05-22
Completion date
Unknown
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Virtual reality-based mindfulness intervention / Virtual reality control) : Random assignments were made to the group using the VR-based mindfulness intervention program and the group using the

Sponsors

Jeonbuk National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The schizophrenia spectrum and other psychotic disorders are according to the diagnostic criteria of DSM-5. Bipolar and related disorders or depressive disorders, accompanied by psychotic symptoms. Those who agree to participate in the study in a stable state after the acute phase psychiatric symptoms were alleviated and can cooperate with and perform questionnaires and tests. SOFAS scores in the range of 41 to 81. PANSS score of less than 85.

Exclusion criteria

Exclusion criteria: Those who are currently in poor health due to serious physical illness If you are pregnant or lactating In case of intellectual disability of IQ 70 or lower Those who have difficulty in consenting and participating in research due to severely impaired reality verification power Those with a PANSS score of 85 or higher or a CGI of 6 or higher Those with a SOFAS score of 40 or lower or 81 or higher Those currently receiving inpatient treatment Those who are not suitable for MRI scans (patients with claustrophobia, artificial pacemakers, blood sugar controllers, patients with attached or possessed metal materials inserted into the body, etc.)

Design outcomes

Primary

MeasureTime frame
- Demographic information and clinical data ?Age, sex, educational background, occupation, marital status, height, weight, physical illness, smoking/drinking level ?Untreated psychotic period (DUP), morbidity period, treatment period, hospitalization history, Suicide attempt experience, medications, drug information (drug content, drug naïve or free status evaluation), community services provided, family history of mental illness, physical illness and treatment status - objective clinical evaluation (40 minutes) ?Psychopathology: positive and Positive and Negative Syndrome Scale (PANSS, Kay et al 1987), PSYRATS-Delusion & Auditory hallucinations, Clinical Global Impression (CGI) (Guy 1976) ?Functional Assessment: Social and Occupational Functioning Assessment Scale (SOFAS, Goldman et al 1992) ?Health Performance Scale (HoNOS) ?Columbia Suicide Severity Rating Scale (C-SSRS) ?Biosignal Measurement: Head-mounted Display Heart rate and RR interval are obtained through PPG (Photoplethysmogrphy) sensor attached to (HMD) - Self-evaluation scale (20 minutes): ?Mindfulness-related scale: Decentralization scale (EQ, Fresco et al 2007; Kwon Seok-man et al. 2010) ), Korean version of the revised Cognitive and Emotional Mindfulness Scale (K-CAMS-R) ?Perceived stress scale ?Subjective Wellbeing under Neuroleptics (SWN-20) ?Motivation and pleasure scale ( Motivation and Pleasure Scale-Self Report; MAP_SR)·Beck Depression Inventory (BDI)

Countries

Korea, Republic of

Contacts

Public ContactYoung-chul Chung

Jeonbuk National University Hospital

chungyc@jbnu.ac.kr+82-63-250-2185

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026